Key facts
- This page summarizes Troy A. Ignelzi's Form 4 filing for Rapport Therapeutics, Inc. (RAPP).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Mar 2025, 17:13.
Troy A. Ignelzi - 12 Mar 2025 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RAPP
- Reported as of
- 12 Mar 2025
- Net transaction value
- +$100,988
- SEC form
- 4
- Accepted by SEC
- 13 Mar 2025, 17:13:57 UTC
- Prior SEC filing
- 04 Feb 2025
- Next SEC filing
- 26 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Troy Ignelzi
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Troy A. Ignelzi filed Form 4 for Rapport Therapeutics, Inc. (RAPP) on 13 Mar 2025.
Change
- Previous filing in this sequence was filed on 04 Feb 2025.
- Current net transaction value: +$100,988.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RAPP
transaction
Common Stock
Purchase
- Transaction value
- $99,990
- Shares
- +9,900
- Change %
- Price
- $10.10
- Shares after
- 9,900
- Date
- 12 Mar 2025
- Ownership
- Direct
RAPP
transaction
Common Stock
Purchase
- Transaction value
- $998
- Shares
- +100
- Change %
- +1%
- Price
- $9.98
- Shares after
- 10,000
- Date
- 13 Mar 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.